Cargando…

ONCE DAILY LITHIUM IN THE PROPHYLAXIS OF MOOD DISORDERS

This retrospective chart review attempts to compare the utility, safety and efficacy of once daily (OD) versus divided dose (DD) lithium therapy in the prophylaxis of mood disorders. Sixty-six patients who met DSM-II1R criteria for mood disorders were grouped into those on OD Lithium (n=31) and thos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohan, Rajesh, Suresh, K.P., Prasad, K.M.R., Ashok, M.V., Andrade, Chittaranjan, Sreenivas, K.N., Chaturvedi, S.K.
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 1996
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2972415/ https://www.ncbi.nlm.nih.gov/pubmed/21584155

Ejemplares similares

ONCE-DAILY VERSUS DIVIDED DOSAGE LITHIUM THERAPY IN ACUTE MANIA
por: Suresh, K.P., et al.
Publicado: (1995)

PSYCHOGERIATRIC PATIENTS - A SOCIODEMOGRAPHIC AND CLINICAL PROFILE
por: Prasad, K.M.R., et al.
Publicado: (1996)

ONCE DAILY RISPERIDONE IN TREATMENT OF SCHIZOPHRENIA
por: Agarwal, Vivek, et al.
Publicado: (2001)

TREATMENT OF AGE-RELATED COGNITIVE DECLINE WITH A HERBAL FORMULATION : A DOUBLE-BLIND STUDY
por: Andrade, Chittaranjan, et al.
Publicado: (1998)

Once-daily dosing of gentamicin.
por: Soper, D E
Publicado: (1998)

A DOUBLE-BLIND, PLACEBO-CONTROLLED EVALUATION OF THE ANXIOLYTIC EFFICACY FF AN ETHANOLIC EXTRACT OF WITHANIA SOMNIFERA
por: Andrade, Chittaranjan, et al.
Publicado: (2000)

A DOUBLE-BLIND, CONTROLLED EVALUATION OF THE EFFICACY AND ADVERSE EFFECT PROFILE OF SUSTAINED-RELEASE ALPRAZOLAM
por: Andrade, Chittaranjan, et al.
Publicado: (2000)

EFFICACY OF LITHIUM PROPHYLAXIS IN BIPOLAR AFFECTIVE DISORDER
por: Mathew, Manu R.K., et al.
Publicado: (1995)

SUBSYNDROMAL SYMPTOMS IN BIPOLAR DISORDER : ROLE OF LITHIUM
por: Andrade, Chittaranjan, et al.
Publicado: (2003)

CARBAMAZEPINE LITHIUM COMBINATION FOR LITHIUM RESISTANT MANIA
por: Desai, Nimesh G., et al.
Publicado: (1986)

PATHOLOGICAL NEUROTOXICITY WITH LITHIUM
por: Andrade, Chittaranjan, et al.
Publicado: (1987)

Effects of Converting Tacrolimus Formulation from Twice-Daily to Once-Daily in Liver Transplantation Recipients
por: Thorat, Ashok, et al.
Publicado: (2014)

Efficacy and safety of once daily dosing of colistin to critically ill patients
por: Skiada, A, et al.
Publicado: (2010)

Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification
por: Toyos, Melissa M.
Publicado: (2019)

Conversion From Twice-Daily Tacrolimus to Once-Daily Extended Release Tacrolimus (LCPT): The Phase III Randomized MELT Trial
por: Bunnapradist, S, et al.
Publicado: (2013)

Use of once-daily raltegravir-based HAART in HIV-infected injection drug users
por: Tossonian, HK, et al.
Publicado: (2010)

SERUM LITHIUM LEVELS WITH SLOW-RELEASE AND CONVENTIONAL LITHIUM CARBONATE PREPARATION
por: Pandey, Ravi S., et al.
Publicado: (1981)

A critical appraisal of once-daily topical luliconazole for the treatment of superficial fungal infections
por: Gupta, Aditya K, et al.
Publicado: (2016)

Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis
por: Kamm, M A, et al.
Publicado: (2008)

A randomized trial of once daily versus twice daily dosing of oral iron in CKD
por: Sood, Vivek, et al.
Publicado: (2023)

Benefits of once-daily therapies in the treatment of hypertension
por: Flack, John M, et al.
Publicado: (2011)

Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin
por: Kapitza, C, et al.
Publicado: (2013)

LITHIUM PROPHYLAXIS IN AFFECTIVE DISORDER
por: Rao, A. Venkoba, et al.
Publicado: (1982)

A prospective cohort conversion study of twice-daily to once-daily extended-release tacrolimus: role of ethnicity
por: Glick, Lauren, et al.
Publicado: (2014)

Mood Stabilisers, but for Lithium, are not stabilizing Moods! Bipolar Disorders: Clinical conundrums 2
por: Reddy, M. S., et al.
Publicado: (2017)

Is once enough? Understanding the preferences of COPD and asthma patients for once- versus twice-daily treatment
por: Horne, Rob
Publicado: (2013)

Lithium not only stabilizes mood, it is also neuroprotective
por: Praharaj, Samir Kumar
Publicado: (2011)

Old but still gold: Lithium in stabilizing the mood
por: Balon, Richard
Publicado: (2009)

Lithium: more than a mood stabilizier
por: Fraga, A., et al.
Publicado: (2022)

Prospective Assessment of Daily Patterns of Mood-Related Symptoms
por: Pilz, Luísa K., et al.
Publicado: (2018)

Antibiotic treatment for intermittent bladder catheterisation with once daily prophylaxis (the AnTIC study): Study protocol for a randomised controlled trial
por: Brennand, Catherine, et al.
Publicado: (2016)

Compliance with Once-Daily versus Twice or Thrice-Daily Administration of Antibiotic Regimens: A Meta-Analysis of Randomized Controlled Trials
por: Falagas, Matthew E., et al.
Publicado: (2015)

THE RELATIONSHIPS OF PLASMA AND ERYTHROCYTE SODIUM, POTASSIUM AND LITHIUM IN LITHIUM PROPHYLAXIS
por: Pradhan, N., et al.
Publicado: (1983)

Impact of Once-Daily Versus Twice-Daily Dosing Frequency on Adherence to Chronic Medications among Patients with Venous Thromboembolism
por: Laliberté, François, et al.
Publicado: (2013)

Once-daily treatment of ADHD with guanfacine: patient implications
por: Strange, Brandon C
Publicado: (2008)

The use of once-daily dosing of gentamicin in obstetrics and gynecology.
por: Wiesenfeld, H C, et al.
Publicado: (1998)

Once-daily transdermal rivastigmine in the treatment of Alzheimer’s disease
por: Wentrup, Andreas, et al.
Publicado: (2009)

Once-daily medications for the pharmacological management of ADHD in adults
por: Tcheremissine, Oleg V, et al.
Publicado: (2009)

Potential benefit of dolutegravir once daily: efficacy and safety
por: Fantauzzi, Alessandra, et al.
Publicado: (2013)

Update on once-daily zonisamide monotherapy in partial seizures
por: Afra, Pegah, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_86np4nsvkbh0cqusauu75dplke